MBX filings
Corporate insider profile
P. Kent Hawryluk Filing Activity
Latest reported as President & CEO of MBX Biosciences, Inc. (MBX).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$17,930.78
- Latest transaction
- May 6, 2026
Affiliated corporations
Reported company relationships
Transaction history
